Antimicrobial drugs used in clinical practice are selected on the basis of their selective
toxicity against bacterial cells. However, all exhibit multiple offsite interactions with …

People living with HIV have a higher risk of developing tuberculosis, and tuberculosis is one
of the leading causes of death among people living with HIV globally. Treating HIV and …

In clinical practice, involuntary vocalizing behaviors are typically associated with Tourette
syndrome and other tic disorders. However, they may also be encountered throughout the …

Psychosis is a state of altered behavior and mentation, and it is rarely reported in preschool
children. Isoniazid is a commonly used drug in the treatment and prophylaxis of tuberculosis …

Isoniazid (INH) is a first-line tuberculosis (TB) drug and is currently recommended as part of
active and latent TB treatment in all ages. INH adverse reactions range from mild hepatitis to …

Diversas guías sobre prevención y control de la tuberculosis indican que en el tratamiento
de la enfermedad infecciosa es fundamentaltener en cuenta la salud mental de los …

Background: Isoniazid is the first line agent for the treatment of tuberculosis. Psychosis is a
known complication of isoniazid therapy, although infrequent. Case report: One female and …

Tuberculosis is one of the top 10 causes of death and the leading cause from a single
infectious agent (above HIV/AIDS). Isoniazid is highly bactericidal against replicating …

Psychosis and hepatotoxicity are the dangerous side effects of the antitubercular drugs
directly observed treatment short course (DOTS) therapy. Hematological spreading of …

Isoniazid is an important component of first-line antitubercular therapy. The drug at its
therapeutic dose is known to cause hepatitis and peripheral neuropathy. The association of …